by 
Key Takeaways
- North America dominated the market with a major share in 2025.
- Asia Pacific is expected to grow at the fastest CAGR between 2026 and 2035.
- By product type, the abdominal aortic stent grafts segment contributed the highest market share in 2025.
- By product type, the thoracic aortic stent grafts segment is expected to grow at a strong CAGR between 2026 and 2035.
- By end-user, the hospitals segment held the biggest market share in 2025.
- By end-user, the ambulatory surgical centers (ASC)/outpatient surgery centers segment is expected to expand at the fastest CAGR between 2026 and 2035.
Market Overview
The global aortic stent grafts market consists of advanced, catheter-delivered medical devices used in endovascular procedures to treat aortic aneurysms and dissections. These grafts are typically made from biocompatible materials such as nitinol or stainless steel combined with specialized fabric coverings. They are inserted into the aorta commonly through the femoral artery to create a reinforced channel for blood flow, thereby preventing aneurysm rupture.
Market growth is primarily driven by the rising prevalence of cardiovascular diseases and the growing preference for minimally invasive procedures over traditional open surgery. Endovascular techniques have become the standard of care for many patients due to reduced recovery time, lower complication risks, and shorter hospital stays. Aortic stent grafts are widely used in treating both abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), supporting sustained global demand.
How AI is Transforming the Aortic Stent Grafts Market
Artificial intelligence (AI) is playing an increasingly critical role in enhancing procedural accuracy, optimizing preoperative planning, and improving patient-specific outcomes in endovascular repair.
AI-powered imaging algorithms automate the analysis of CT scans by segmenting vascular structures, identifying pathologies, and quantifying plaque burden with high precision. These capabilities enable more accurate diagnosis and risk assessment.
AI also supports device sizing and selection by automatically measuring key anatomical parameters such as aortic diameter, angulation, landing zones, and coronary ostia height. This improves stent graft selection, reduces operative time, and minimizes the risk of complications such as endoleaks or improper deployment.
Additionally, AI contributes to product innovation by assisting manufacturers in design simulation, stress modeling, and quality control processes. Advanced computational modeling helps enhance stent flexibility, sealing performance, and long-term durability.
Major Trends in the Aortic Stent Grafts Market
- Growing Demand for Minimally Invasive Procedures: There is a sustained shift from open surgical repair to minimally invasive endovascular techniques, including Endovascular Aneurysm Repair (EVAR) for abdominal aortic aneurysms and Thoracic Endovascular Aortic Repair (TEVAR) for thoracic aneurysms. These procedures offer reduced surgical trauma, shorter recovery times, and improved patient outcomes.
- Rise of Complex and Customized Stent Grafts: As physicians increasingly treat complex anatomies such as juxtarenal, pararenal, and aortic arch aneurysms the demand for customized and branched stent grafts is rising. Personalized solutions are designed to accommodate tortuous or highly variable aortic structures, improving procedural success rates.
- Advancements in Material Science and Delivery Systems: Manufacturers are focusing on next-generation materials and coatings that enhance durability, reduce thrombosis risk, and improve long-term performance. Low-profile delivery systems are also being developed to allow access through smaller vessels, expanding eligibility to a broader patient population.
- Integration of AI and Digital Planning Tools: AI-driven planning software and advanced imaging technologies are becoming essential components of preoperative assessment and intraoperative navigation. These tools improve procedural accuracy, reduce complication rates, and enhance long-term graft performance monitoring.
Regional Insights
North America currently dominates the global aortic stent grafts market, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and widespread adoption of minimally invasive procedures such as EVAR and TEVAR. The United States accounts for the largest regional share due to strong insurance coverage, high procedural volumes, and continued investments in advanced medical technologies. Additionally, increased awareness among clinicians and patients regarding endovascular therapy benefits supports consistent market demand.
Europe holds a significant portion of the aortic stent grafts market, supported by established healthcare systems and growing geriatric populations vulnerable to aortic aneurysms. Countries such as Germany, the United Kingdom, France, and Italy are major contributors to regional market growth. European regulatory support for innovative medical devices, along with reimbursement frameworks that favor minimally invasive therapies, further encourages the adoption of next-generation stent grafts across hospitals and vascular centers.
The Asia-Pacific region is poised for the fastest market growth over the forecast period. Rapid improvements in healthcare infrastructure, increasing access to advanced cardiovascular care, and rising awareness of minimally invasive treatment options are key drivers. Countries including China, Japan, India, and South Korea are experiencing increased procedural adoption rates due to rising incidences of aortic aneurysms, expanding insurance coverage, and continued investments in diagnostic imaging and surgical technologies. Growth in medical tourism and government initiatives to improve surgical outcomes further support market expansion.
Aortic Stent Grafts Market Key Players
- Medtronic PLC
- W. L. Gore and Associates, Inc.
- Cook Medical Inc.
- Terumo Corporation / Terumo Aortic
- Endologix LLC
- Artivion, Inc.
- MicroPort Scientific Corporation
- Cardinal Health Inc.
- Becton, Dickinson and Company (BD)
- Lombard Medical, Inc.
- Bentley InnoMed GmbH
- Braile Biomédica
- Endospan Ltd.
- LifeTech Scientific Corporation
- Edwards Lifesciences Corporation
Recent Developments
- In January 2025, Bentley introduced two products at the Leipzig Interventional Course: the BeGraft stent graft system and the BeFlared fenestrated endovascular aneurysm repair (FEVAR) stent graft system. According to CEO Sebastian Büchert, this launch signifies a significant moment amidst new EU Medical Device Regulations, highlighting a major advancement for endovascular specialists. This stent features a stepped balloon design for easier deployment and a third radiopaque marker for precise positioning.
- In June 2024, Medtronic launched the Steerant aortic guidewire, designed to assist with catheter placement during procedures like EVAR. The guidewire, available in single- and double-curve configurations, combines a soft, atraumatic tip with a stiff main body for better anatomy protection. It has a diameter of 0.035 inches and comes in lengths suitable for EVAR and TEVAR. The first EVAR using this device was successfully performed by Dr. Naiem Nassiri at Norwalk Hospital in Connecticut.
- In May 2023, Terumo Aortic announced FDA approval of the RelayPro Thoracic Stent-Graft for treating aneurysm, dissection, transection, and penetrating atherosclerotic ulcers in the descending thoracic artery. Offering the lowest commercial profile, wide size range, and precise deployment, RelayPro enhances thoracic endovascular aortic repair (TEVAR) for patients with smaller access vessels while ensuring durability and clinical efficacy.
Segments Covered in the Report
By Product Type
- Abdominal Aortic Stent Graft
- Thoracic Aortic Stent Graft
By End-User
- Hospitals
- ASC/Outpatient Surgery Centers
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Get Sample Link : https://www.precedenceresearch.com/sample/7812
